Skip to main content
Log in

Effect of radioprotector indralin on carboplatinum hemotoxicity

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

A decrease in carboplatinum hemotoxicity was detected in experiments on C57Bl mice treated with the drug in combination with indralin (urgent radioprotector). Carboplatinum in a dose of 125 mg/kg, injected intraperitoneally, caused 80–100% death; the median term of death was 6 days (3–17). Single oral dose of indralin (100 mg/kg) during the 1st min or 15 min after carboplatinum injection (125 mg/kg) increased animal survival by 40.0–46.7% by day 20 of the experiment primarily during the period of manifest hemotoxicity (days 7–17), indralin injected 1, 2, or 4 h after carboplatinum exhibited no chemoprotective effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. V. Vasin, I. B. Ushakov, L. A. Semenova, and V. Yu. Kovtun, Radiats. Biol. Radioekol., 41, No. 3, 307–309 (2001).

    CAS  Google Scholar 

  2. L. A. Il’in, N. M. Rudnyi, N. N. Suvorov, et al., Indralin: Urgent Radioprotector. Antiradiation Effects, Pharmacology, Mechanism of Action, Clinical Picture [in Russian], Moscow (1994).

  3. M. K. Pulatova, V. L. Sharygin, and T. G. Shlyakova, Radiats. Biol. Radioekol., 43, No. 1, 29–43 (2003).

    CAS  Google Scholar 

  4. G. A. Chernov, T. G. Shlyakova, V. L. Sharygin, et al., Izv. Akad. Nauk, ser. Biology, No. 1, 20–37 (1994).

  5. C. S. Broome and J. A. Miyan, Ann. NY Acad. Sci., 917, 424–434 (2000).

    Article  PubMed  CAS  Google Scholar 

  6. G. J. Maestroni, Pharmacol. Res., 32, No. 5, 249–253 (1995).

    Article  PubMed  CAS  Google Scholar 

  7. G. J. Maestroni, Ann. N.Y. Acad. Sci., 917, 29–37 (2000).

    Article  PubMed  CAS  Google Scholar 

  8. G. J. Maestroni and A. Conti, Exp. Hematol., 22, No. 3, 313–320 (1994).

    PubMed  CAS  Google Scholar 

  9. G. J. Maestroni and A. Conti, Int. J. Immunopharmacol., 16, No. 2, 117–122 (1994).

    Article  PubMed  CAS  Google Scholar 

  10. G. J. Maestroni, A. Conti, and E. Pedrinis, Blood, 80, 1178–1182 (1992).

    PubMed  CAS  Google Scholar 

  11. G. J. Maestroni, M. Togni, and V. Covacci, Exp. Hematol., 25, No. 6, 491–494 (1997).

    PubMed  CAS  Google Scholar 

  12. V. Santini, Exp. Opin. Pharmacother., 2, No. 3, 479–489 (2001).

    Article  CAS  Google Scholar 

  13. C. Savoye, C. Swenberg, S. Hugot, et al., Int. J. Radiat. Biol., 71, No. 2, 193–202 (1997).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 141, No. 4, pp. 422–424, April, 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasin, M.V., Ushakov, I.B., Kovtun, V.Y. et al. Effect of radioprotector indralin on carboplatinum hemotoxicity. Bull Exp Biol Med 141, 437–439 (2006). https://doi.org/10.1007/s10517-006-0193-1

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-006-0193-1

Key Words

Navigation